GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OTCPK:VIMGF) » Definitions » Price-to-Owner-Earnings

VIMGF (Vimian Group AB) Price-to-Owner-Earnings : 45.00 (As of May. 02, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Vimian Group AB Price-to-Owner-Earnings?

As of today (2025-05-02), Vimian Group AB's share price is $4.50. Vimian Group AB's Owner Earnings per Share (TTM) ended in Mar. 2025 was $0.10. It's Price-to-Owner-Earnings for today is 45.00.


The historical rank and industry rank for Vimian Group AB's Price-to-Owner-Earnings or its related term are showing as below:

VIMGF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 41.12   Med: 51   Max: 87.62
Current: 45.89

During the past 8 years, the highest Price-to-Owner-Earnings of Vimian Group AB was 87.62. The lowest was 41.12. And the median was 51.00.


VIMGF's Price-to-Owner-Earnings is ranked worse than
76.06% of 71 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.95 vs VIMGF: 45.89

As of today (2025-05-02), Vimian Group AB's share price is $4.50. Vimian Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $0.04. Therefore, Vimian Group AB's PE Ratio (TTM) for today is 118.42.

As of today (2025-05-02), Vimian Group AB's share price is $4.50. Vimian Group AB's EPS without NRI for the trailing twelve months (TTM) ended in was $0.04. Therefore, Vimian Group AB's PE Ratio without NRI for today is 118.42.

During the past 8 years, Vimian Group AB's highest PE Ratio without NRI was 706.04. The lowest was 2.53. And the median was 82.71.


Vimian Group AB Price-to-Owner-Earnings Historical Data

The historical data trend for Vimian Group AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Price-to-Owner-Earnings Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - 43.75

Vimian Group AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 44.67 82.40 43.75 50.00

Competitive Comparison of Vimian Group AB's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Vimian Group AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Price-to-Owner-Earnings falls into.


;
;

Vimian Group AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vimian Group AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4.50/0.10
=45.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB  (OTCPK:VIMGF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vimian Group AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.